Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898082193> ?p ?o ?g. }
- W2898082193 endingPage "viii576" @default.
- W2898082193 startingPage "viii576" @default.
- W2898082193 abstract "Background: We report on the characteristics and determinants of outcome of the 35784 pts included in the nationwide NETSARC/RREPS study since its inception. Methods: NETSARC (netsarc.org) is a network of 26 reference sarcoma centers with specialized multidisciplinary tumor boards (MDTB), funded by the French National Cancer Institute to improve the outcome of sarcoma patients. Since 2010, presentation to an MDTB and second pathological review are mandatory for sarcoma patients. Patients’ characteristics and follow-up are collected in a database regularly monitored. Descriptive, uni and multivariate analysis of prognostic factors were conducted in the incident (n = 29497) pts population as well as on pts diagnosed before 1/1/2010 (n = 6287), presented to an MDTB after 1/1/10. Results: We first investigated predisposing and associated conditions: among the 35784, previous cancer, previous RT, NF1, Li-Fraumeni, were reported in 12.5%, 3.6%, 0.7%, 0.1% of pts respectively. 71 of the 35784 (0.2%) pts had 2 or 3 different diagnosis of sarcomas: 28%, 7%, 6%, 3% of these pts had an history of previous cancer, NF1, Li-Fraumeni, Ollier disease (p < 0.001). Prognostic factors of pts outcome at initial diagnosis were then analyzed: male gender, age, size, depth, grade 3, NF1, previous RT were all associated with a worse overall (OS) and progression free survival (PFS) in the incident pts population in univariate and multivariate analysis, while GIST, intermediate malignancy histologies, and surgery in a Netsarc center (HR:0,63) were positively correlated with OS and PFS (p < 0.001 for all). Similar results were obtained in the 6287 pts diagnosed before 2010 for OS. In pts in advanced phase, survival was superior to that reported in the literature with a median of 27 months for all sarcomas but GIST. Median OS was not reached for GIST and tumor of intermediate malignancy (58% and 76% at 5 years respectively). NF1, previous RT, and treatment outside a reference center were again associated with a worse OS in multivariate analysis. Conclusions: In this nationwide registry of sarcoma patients, unreported prognostic characteristics sarcoma pts were identified.Treatment in a reference center reduces the risk of relapse and death. Legal entity responsible for the study: NETSARC and French Sarcoma Group. Funding: French NCI ( INCA). Disclosure: J-Y. Blay: Research support and honoraria: Roche, Novartis, Bayer, GSK, Lilly, MSD, BMS, Ignyta, Deciphera, PharmaMar. All other authors have declared no conflicts of interest." @default.
- W2898082193 created "2018-10-26" @default.
- W2898082193 creator A5003536346 @default.
- W2898082193 creator A5004048701 @default.
- W2898082193 creator A5005545439 @default.
- W2898082193 creator A5012166159 @default.
- W2898082193 creator A5020591127 @default.
- W2898082193 creator A5020672869 @default.
- W2898082193 creator A5034875672 @default.
- W2898082193 creator A5037214360 @default.
- W2898082193 creator A5058395773 @default.
- W2898082193 creator A5060949051 @default.
- W2898082193 creator A5065856111 @default.
- W2898082193 creator A5065859370 @default.
- W2898082193 creator A5066221687 @default.
- W2898082193 creator A5071292317 @default.
- W2898082193 creator A5074959994 @default.
- W2898082193 creator A5076354847 @default.
- W2898082193 creator A5080620486 @default.
- W2898082193 creator A5084836759 @default.
- W2898082193 creator A5090103193 @default.
- W2898082193 creator A5091721810 @default.
- W2898082193 date "2018-10-01" @default.
- W2898082193 modified "2023-09-23" @default.
- W2898082193 title "Natural history of sarcomas and impact of reference centers in the nationwide NETSARC study on 35,784 patients (pts) from 2010 to 2017" @default.
- W2898082193 doi "https://doi.org/10.1093/annonc/mdy299" @default.
- W2898082193 hasPublicationYear "2018" @default.
- W2898082193 type Work @default.
- W2898082193 sameAs 2898082193 @default.
- W2898082193 citedByCount "8" @default.
- W2898082193 countsByYear W28980821932019 @default.
- W2898082193 countsByYear W28980821932020 @default.
- W2898082193 countsByYear W28980821932021 @default.
- W2898082193 countsByYear W28980821932022 @default.
- W2898082193 countsByYear W28980821932023 @default.
- W2898082193 crossrefType "journal-article" @default.
- W2898082193 hasAuthorship W2898082193A5003536346 @default.
- W2898082193 hasAuthorship W2898082193A5004048701 @default.
- W2898082193 hasAuthorship W2898082193A5005545439 @default.
- W2898082193 hasAuthorship W2898082193A5012166159 @default.
- W2898082193 hasAuthorship W2898082193A5020591127 @default.
- W2898082193 hasAuthorship W2898082193A5020672869 @default.
- W2898082193 hasAuthorship W2898082193A5034875672 @default.
- W2898082193 hasAuthorship W2898082193A5037214360 @default.
- W2898082193 hasAuthorship W2898082193A5058395773 @default.
- W2898082193 hasAuthorship W2898082193A5060949051 @default.
- W2898082193 hasAuthorship W2898082193A5065856111 @default.
- W2898082193 hasAuthorship W2898082193A5065859370 @default.
- W2898082193 hasAuthorship W2898082193A5066221687 @default.
- W2898082193 hasAuthorship W2898082193A5071292317 @default.
- W2898082193 hasAuthorship W2898082193A5074959994 @default.
- W2898082193 hasAuthorship W2898082193A5076354847 @default.
- W2898082193 hasAuthorship W2898082193A5080620486 @default.
- W2898082193 hasAuthorship W2898082193A5084836759 @default.
- W2898082193 hasAuthorship W2898082193A5090103193 @default.
- W2898082193 hasAuthorship W2898082193A5091721810 @default.
- W2898082193 hasBestOaLocation W28980821931 @default.
- W2898082193 hasConcept C121608353 @default.
- W2898082193 hasConcept C126322002 @default.
- W2898082193 hasConcept C141071460 @default.
- W2898082193 hasConcept C142724271 @default.
- W2898082193 hasConcept C143998085 @default.
- W2898082193 hasConcept C144301174 @default.
- W2898082193 hasConcept C2778256501 @default.
- W2898082193 hasConcept C2779399171 @default.
- W2898082193 hasConcept C2908647359 @default.
- W2898082193 hasConcept C38180746 @default.
- W2898082193 hasConcept C71924100 @default.
- W2898082193 hasConcept C99454951 @default.
- W2898082193 hasConceptScore W2898082193C121608353 @default.
- W2898082193 hasConceptScore W2898082193C126322002 @default.
- W2898082193 hasConceptScore W2898082193C141071460 @default.
- W2898082193 hasConceptScore W2898082193C142724271 @default.
- W2898082193 hasConceptScore W2898082193C143998085 @default.
- W2898082193 hasConceptScore W2898082193C144301174 @default.
- W2898082193 hasConceptScore W2898082193C2778256501 @default.
- W2898082193 hasConceptScore W2898082193C2779399171 @default.
- W2898082193 hasConceptScore W2898082193C2908647359 @default.
- W2898082193 hasConceptScore W2898082193C38180746 @default.
- W2898082193 hasConceptScore W2898082193C71924100 @default.
- W2898082193 hasConceptScore W2898082193C99454951 @default.
- W2898082193 hasLocation W28980821931 @default.
- W2898082193 hasOpenAccess W2898082193 @default.
- W2898082193 hasPrimaryLocation W28980821931 @default.
- W2898082193 hasRelatedWork W1987677298 @default.
- W2898082193 hasRelatedWork W2030729277 @default.
- W2898082193 hasRelatedWork W2034204715 @default.
- W2898082193 hasRelatedWork W2094620610 @default.
- W2898082193 hasRelatedWork W2106198267 @default.
- W2898082193 hasRelatedWork W2361700749 @default.
- W2898082193 hasRelatedWork W2412290794 @default.
- W2898082193 hasRelatedWork W2471405966 @default.
- W2898082193 hasRelatedWork W2614970116 @default.
- W2898082193 hasRelatedWork W2970752085 @default.
- W2898082193 hasVolume "29" @default.
- W2898082193 isParatext "false" @default.
- W2898082193 isRetracted "false" @default.
- W2898082193 magId "2898082193" @default.